Whoop Moves into Blood Testing — Can ZP-SenseItAll Take It Further?

Zimmer and Peacock is an ISO13485 contract developer and manufacturer of technologies for clients with an ambition to make a difference in health and wellness through PoC Diagnostics and Wearable Biosensors. 

Whoop Moves into Blood Testing — Can ZP-SenseItAll Take It Further?

Whoop, the fitness tech company backed by Cristiano Ronaldo, is making waves again — this time by expanding beyond wearables into blood testing. The company recently announced the upcoming launch of Whoop Advanced Labs, a new service aimed at integrating clinical-grade blood diagnostics with its health-tracking platform.

Set to launch in the U.S. later in 2025, Advanced Labs will enable members to schedule periodic blood tests, have samples reviewed by clinicians, and view detailed health reports through the Whoop app. These reports will cover areas like heart health, metabolism, inflammation, hormonal balance, and immune function.

But while this is a big leap for fitness trackers, it still follows the traditional model: blood samples are collected and sent to a lab for analysis.

Enter ZP-SenseItAll: Blood Testing Without Leaving Home

This is where ZP-SenseItAll offers a compelling advancement.

ZP-SenseItAll is a cutting-edge biosensing technology developed by Zimmer and Peacock that allows monitoring of analytes in blood — without the need to send samples to a lab. The technology uses electrochemical sensors integrated into a compact point-of-care device, enabling point-of-need measurement of analytes in the blood.

The great advantage of the ZP-SIA platform is that it is already Cloud-enabled, with all raw data sent to the Cloud, so it fits naturally into the digital workflow of Whoop or similar data-driven platforms. This compatibility opens the door to seamless integration between real-time biosensing and Whoop’s advanced health analytics ecosystem.

Where Whoop’s Advanced Labs requires a periodic test administered externally, ZP-SenseItAll proposes an at-home blood testing solution, offering immediate access to health insights and reducing the lag time between sampling and diagnosis.

Side-by-Side: Whoop Advanced Labs vs ZP-SenseItAll

Empowering Platforms Like Whoop

Rather than being a competitor, ZP-SenseItAll technology can empower platforms like Whoop by adding a crucial layer of biochemical insight to their existing health monitoring ecosystems. Imagine a system where Whoop wearables continuously track vital signs, and ZP-SIA provides real-time biochemical data — all integrated into a single, cloud-connected health dashboard.

This combination could dramatically expand the value and utility of Whoop’s platform, transforming it from a fitness tracker into a more comprehensive, health decision-support tool. By bridging the gap between consumer-grade tracking and clinical-level diagnostics, ZP-SIA enhances the personalization, responsiveness, and medical relevance of digital health platforms — making healthcare faster, more accessible, and more actionable.

The Future of Health Monitoring

Whoop’s move into blood diagnostics signals a clear industry shift toward more complete, personalized health insights. But as technologies like ZP-SenseItAll emerge, the future might look less like sending vials to a lab — and more like checking your health in real time, right from your living room.

By enabling lab-free, decentralized testing, ZP-SenseItAll represents a crucial step toward democratizing healthcare, reducing friction, and empowering users with instant insights — precisely the direction modern health tech should be heading.